scispace - formally typeset
R

Radhika Gogoi

Researcher at Geisinger Medical Center

Publications -  47
Citations -  471

Radhika Gogoi is an academic researcher from Geisinger Medical Center. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 10, co-authored 30 publications receiving 361 citations. Previous affiliations of Radhika Gogoi include New York University & Lankenau Medical Center.

Papers
More filters
Journal ArticleDOI

Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells.

TL;DR: The results suggest that VP is a promising chemotherapeutic agent for the treatment of endometrial cancer.
Journal ArticleDOI

The tumor microenvironment: key to early detection.

TL;DR: The tumor microenvironment plays an important role equal to the tumor cell population in the progression of cancer as discussed by the authors, and the surrounding environment interacts or "cross-talks" with tumor cells through the release of growth factors, cytokines, proteases, and other bioactive molecules.
Journal ArticleDOI

Yes-associated protein (YAP) modulates oncogenic features and radiation sensitivity in endometrial cancer.

TL;DR: Increased nuclear YAP expression was significantly associated with higher grade, stage, lympho-vascular space invasion, postoperative recurrence/metastasis and overall survival in estrogen mediated EMCA, called type 1 cancer.
Journal ArticleDOI

Association Between Pulmonary Mycobacterium Avium Complex Infection and Lung Cancer

TL;DR: The percentage of smokers among women with both MAC and lung cancer was lower than among the lung cancer control group who did not grow MAC, and the presence of MAC in respiratory cultures of lung cancer patients was particularly associated with squamous cell carcinomas located in the periphery of the lung.
Journal ArticleDOI

Randomized Trial of Exercise on Quality of Life in Women With Ovarian Cancer: Women's Activity and Lifestyle Study in Connecticut (WALC).

TL;DR: A six-month home-based, telephone-delivered exercise intervention of primarily brisk walking to be associated with improved physical HRQOL in women with ovarian cancer and oncologists and primary care providers should recommend and refer women diagnosed with ovarian cancer to clinic- or community-based exercise programs.